Healius Limited Stock Price

ASX:HLS Community·AU$275.9m Market Cap

3 Narratives written by author
0 Comments on narratives written by author
38 Fair Values set on narratives written by author

Author Program NEW Create Narrative

HLS Share Price Performance

AU$0.38

-0.40 (-51.28%)

AU$0.37

Fair Value

AU$0.38

-0.40 (-51.28%)

2.7% overvalued

AU$0.37

Fair Value

AU$0.38

AU$0.37

AU$1.05

AU$0.51

Fri, 21 Aug 26

Fair ValueAU$0.37

Share Pricen/a

HLS Community Narratives

AnalystLowTarget's

Fair Value

Fair Value AU$0.37 2.7% overvalued

Digital And Labor Pressures Will Limit Pathology Margins And Earnings Recovery

AnalystHighTarget's

Fair Value

Fair Value AU$1.05 63.8% undervalued

Genomic And Specialist Diagnostics Expansion Will Support A Stronger Long Term Outlook

AnalystConsensusTarget's

Fair Value

Fair Value AU$0.51 26.1% undervalued

Digital Automation And Genomics Expansion Will Support A Stronger Long Term Pathology Business

Healius

2.7% overvalued

Digital And Labor Pressures Will Limit Pathology Margins And Earnings Recovery

AnalystLowTarget

Updated 21 Aug

Read Narrative

Healius

63.8% undervalued

Genomic And Specialist Diagnostics Expansion Will Support A Stronger Long Term Outlook

AnalystHighTarget

Updated 24 Jul

Read Narrative

Healius

26.1% undervalued

Digital Automation And Genomics Expansion Will Support A Stronger Long Term Pathology Business

AnalystConsensusTarget

Updated 10 Jul

Read Narrative

Trending Discussion

No trending discussion available.

Snowflake Analysis

Undervalued with moderate growth potential.

0 Risks

3 Rewards

View Full Analysis

Healius Limited Key Details

Last Reported Earnings

Jun 30, 2026

Next Reporting Earnings

n/a

: -0.56
: 29.92%
: -29.78%
: 57.9%

View Full Analysis

About HLS

Founded: 1994
Employees: 6000
CEO: Paul Anderson
WebsiteView website: www.healius.com.au

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.